Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance

Transplant International

Volumn 17, Issue 12, 2004, Pages 795-803

  Iwai, Toshiro ^a   Tomita, Yukihiro ^a   Zhang, Qi Wei ^a   Shimizu, Ichiro ^a   Nomoto, Kikuo ^b   Yasui, Hisataka ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Adoptive transfer; Chimerism; Clonal destruction; Cyclophosphamide; Skin allograft tolerance

Indexed keywords

CYCLOPHOSPHAMIDE;

ADOPTIVE TRANSFER; ANIMAL CELL; BONE MARROW CELL; CHIMERA; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLOGRAFT; SKIN TRANSPLANTATION; SPLEEN CELL; T CELL DEPLETION; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE;

EID: 23944526117     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1007/s00147-003-0675-2     Document Type: Conference Paper

References (32)

1. Billingham RE, Brent L, Medawar PB. "Actively acquired tolerance" of foreign cells. Nature 1953; 172:603.
2. Cobbold SP, Martin G, Qin S, Waldmann H. Monoclonal antibodies to promote engraftment and tissue graft tolerance. Nature 1989; 323:164.
3. Good RA, Martinez C, Gabrielson AE. Progress toward transplantation of tissues in man. In: Advances in pediatrics, Vol. 13. Chicago: Year Book Medical Publishers, 1964:93.
4. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307:168.
5. Lubaroff DM, Silvers WK. The importance of chimerism in maintaining tolerance of skin allografts in mice. J Immunol 1973; 111:65.
6. Main JM, Prehn RT. Successful skin homografts after the administration of high dosage X radiation and homologous bone marrow. J Natl Cancer Inst 1955; 15:1023.
7. Monaco AP, Wood ML, Russell PS. Studies on heterogous anti-lymphocyte serum in mice. III. Immunologic tolerance and chimerism produced across the H-2 locus with adult thymectomy and anti-lymphocyte serum. Ann N Y Acad Sci 1966; 129:190.
8. Morecki S, Leshem B, Eid A, Slavin S. Alloantigen persistence in induction and maintenance of transplantation tolerance. J Exp Med 1987; 165:1468.
9. Qin S, Cobbold SP, Benjamin RB, Waldmann H. Induction of classical transplantation tolerance in the adult. J Exp Med 1989; 169:779.
10. Rapaport FT, Watanabe K, Cannon FD, Mollen N, Blumenstock DA, Ferrebee JW. Histocompatibility studies in a closely bred colony of dogs. IV. Tolerance to bone marrow, kidney, and skin allografts in DLA-identical radiation chimera. J Exp Med 1972; 136:1080.
11. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989; 169:493.
12. Slavin S, Strober S, Fuks Z, Kaplan HS. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J Exp Med 1977; 140:34.
13. Morrissey PJ, Sharrow SO, Kohno Y, Berzofsky JA, Singer A. Correlation of intrathymic tolerance with intrathymic chimerism in neonatally tolerized mice. Transplantation 1985; 40:68.
14. Elwood ET, Larsen CP, Maurer DH, et al. Microchimerism and rejection in clinical transplantation. Lancet 1997; 349:1358.
15. Hisanaga M, Hundrieser J, Boker K, et al. Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation. Transplantation 1996; 61:40.
16. Zhang QW, Tomita Y, Matsuzaki G, et al. Mixed chimerism, heart, and skin allograft tolerance in cyclophosphamide-induced tolerance. Transplantation 2000; 70:906.
17. Tomita Y, Mayumi H, Eto M, Nomoto K. Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance? J Immunol 1990; 144:463.
18. Kulander RJ, Ellison DM, Hall J. The blockade of Fc receptor-mediated clearance of immune complexes in vivo by a monoclonal antibody (2.4G2) directed against Fc receptors on murine leukocytes. J Immunol 1984; 133:855.
19. Eto M, Mayumi H, Tomita Y, Yoshikai Y, Nishimura Y, Nomoto K. Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion. J Immunol 1990; 145:1303.
20. + T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mis-disparate antigens. J Exp Med 1990; 171:97.
21. Tomita Y, Nishimura Y, Harada N, et al. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion. J Immunol 1990; 145:4026.
22. Sykes M, Sheard M, Sachs DH. Effects of T cell depletion in radiation bone marrow chimeras. I. Evidence for a donor cell population which increases allogeneic chimerism but which lacks the potential to produce GVHD. J Immunol 1988; 141:2282.
23. Sykes M, Sheard M, Sachs DH. Effects of T cell depletion in radiation bone marrow chimeras. II. Requirement for allogeneic T cells in the reconstituting bone marrow inoculum for subsequent resistance to breaking of tolerance. J Exp Med 1988; 168:661.
24. Sykes M, Sheard M, Sachs DH. Effects of T cell depletion in radiation bone marrow chimeras. III. Characterization of allogeneic bone marrow cell populations that increase allogeneic chimerism independently of graft-vs-host disease in mixed marrow recipients. J Immunol 1989; 143:3503.
25. Soulillou JP, Blandin F, Gunther E, Lemoine V. Genetics of the blood transfusion effect on heart allografts in rats. Transplantation 1984; 38:63.
26. Shin T, Mayumi H, Himeno K, Sanui H, Nomoto K. Drug-induced tolerance to allografts in mice. I. Difference between tumor and skin grafts. Transplantation 1984; 37:580.
27. Zhang QW, Mayumi H, Umesue M, Tomita Y, Nomoto K, Yasui H. Fractionated dosing of cyclophosphamide for establishing long-lasting skin allograft survival, stable mixed chimerism, and intrathymic clonal deletion in mice primed with allogeneic spleen cells. Transplantation 1997; 63:1667.
28. Taniguchi H, Abe M, Shirai T, Fukao K, Nakauchi H. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras. J Immunol 1995; 155:5631.
29. Harada M, Tomita Y, Matsuzaki G, Miyamoto Y, Nomoto K. Alloreactivity against IE-encoded alloantigens: evidence of discrepancy between graft rejection and IE-reactive cells. Cell Immunol 1992; 143:420.
30. Tomita Y, Khan A, Sykes M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a non-myeloablative regimen. J Immunol 1994; 153:1087.
31. Prigozhina TB, Grevitch O, Zhu J, Slavin S. Permanent and specific transplantation tolerance induced by a non-myeloablative treatment to a wide variety of allogeneic tissues. Transplantation 1997; 63:1394.
32. Zamoyska R, Waldmann H, Matzinger P. Peripheral tolerance mechanisms prevent the development of autoreactive T cells in chimeras grafted with two minor incompatible thymuses. Eur J Immunol 1989; 19:111.